TMCnet News
Global Radiation Oncology Market 2017-2021 - Key Vendors are Accuray, C. R. Bard, Elekta, IBA Worldwide & Varian Medical Systems - Research and MarketsThe "Global Radiation Oncology Market 2017-2021" report has been added to Research and Markets' offering. The global radiation oncology market to grow at a CAGR of 5.29% during the period 2017-2021. Global Radiation Oncology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market. One trend in the market is strategic collaborations and M&A. Strategic M&A and collaborations are becoming common in the global radiation oncology market. Key vendors are pursuing M&A to strengthen their market positions and expand their product portfolios. Many vendors are also collaborating with other vendors to expand their market presence. According to the report, one driver in the market is increasing incidence of cancer. The incidence of cancers such as lung, breast, prostate, colorectal, and stomach is increasing. In 2012, the global incidence of cancer was approximately two million for billion pople. In 2015, the global mortality from cancer was approximately 1,200 for million people. Lung cancer is the most common cancer across the world. In 2012, the global incidence of lung cancer was approximately 250,000 for billion people. Breast cancer is the second most common cancer across the world. In 2012, the global incidence of breast cancer was approximately 240,000 for billion people. Further, the report states that one challenge in the market is lack of access to radiotherapy. There is a lack of access to radiotherapy due to shortage in investments. Low healthcare expenditure, shortage of equipment, and shortage of trained staff and facilities have resulted in the low adoption of radiation equipment. There is a global shortage of radiotherapy services, with more than 90% of all cancer patients in low-income countries lacking access to radiotherapy. Most installed LINACs are in high-income countries. Key vendors
Other prominent vendors
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/m4t9b2/global_radiation
View source version on businesswire.com: http://www.businesswire.com/news/home/20171017006174/en/ |
